1. Home
  2. SOBR vs LIXT Comparison

SOBR vs LIXT Comparison

Compare SOBR & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SOBR
  • LIXT
  • Stock Information
  • Founded
  • SOBR 2004
  • LIXT 2005
  • Country
  • SOBR United States
  • LIXT United States
  • Employees
  • SOBR N/A
  • LIXT N/A
  • Industry
  • SOBR Newspapers/Magazines
  • LIXT Biotechnology: Pharmaceutical Preparations
  • Sector
  • SOBR Consumer Discretionary
  • LIXT Health Care
  • Exchange
  • SOBR Nasdaq
  • LIXT Nasdaq
  • Market Cap
  • SOBR 423.2K
  • LIXT 2.2M
  • IPO Year
  • SOBR N/A
  • LIXT N/A
  • Fundamental
  • Price
  • SOBR $3.09
  • LIXT $2.83
  • Analyst Decision
  • SOBR
  • LIXT
  • Analyst Count
  • SOBR 0
  • LIXT 0
  • Target Price
  • SOBR N/A
  • LIXT N/A
  • AVG Volume (30 Days)
  • SOBR 28.0K
  • LIXT 5.8M
  • Earning Date
  • SOBR 08-11-2025
  • LIXT 08-07-2025
  • Dividend Yield
  • SOBR N/A
  • LIXT N/A
  • EPS Growth
  • SOBR N/A
  • LIXT N/A
  • EPS
  • SOBR N/A
  • LIXT N/A
  • Revenue
  • SOBR $251,363.00
  • LIXT N/A
  • Revenue This Year
  • SOBR N/A
  • LIXT N/A
  • Revenue Next Year
  • SOBR N/A
  • LIXT N/A
  • P/E Ratio
  • SOBR N/A
  • LIXT N/A
  • Revenue Growth
  • SOBR 59.68
  • LIXT N/A
  • 52 Week Low
  • SOBR $2.41
  • LIXT $0.64
  • 52 Week High
  • SOBR $195.46
  • LIXT $4.25
  • Technical
  • Relative Strength Index (RSI)
  • SOBR 43.53
  • LIXT 81.62
  • Support Level
  • SOBR $2.91
  • LIXT $0.68
  • Resistance Level
  • SOBR $3.24
  • LIXT $0.93
  • Average True Range (ATR)
  • SOBR 0.23
  • LIXT 0.38
  • MACD
  • SOBR -0.00
  • LIXT 0.17
  • Stochastic Oscillator
  • SOBR 37.31
  • LIXT 60.66

About SOBR SOBR Safe Inc.

Sobr Safe Inc provides non-invasive technology to quickly and humanely identify the presence of alcohol in individuals. Its technologies are integrated within robust and scalable data platform, producing statistical and measurable user and business data. It developed the scalable, patent-pending SOBRsafe software platform for non-invasive alcohol detection and identity verification, a solution that has current and potential applications. It generates revenue through various combinations of software products and services which include the sale of cloud-based software solutions, detection and data collection hardware devices, and cloud-based data reporting and analysis services.

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

Share on Social Networks: